banner-clinicaltrials

A new option for patients with hypertension

The RADIANCE-HTN clinical trial is a randomized, controlled study to provide additional information about the ability of the Paradise Renal Denervation System to treat high blood pressure.  The study is designed to evaluate the Paradise Renal Denervation System both in patients currently uncontrolled on three or more blood pressure medications, termed “resistant hypertension” and also in patients taking two or less blood pressure medications to manage their blood pressure.  In the study, half of the patients will receive the ultrasound therapy and half of the patients will receive a “sham” therapy (no ultrasound treatment).  Participants will not be told which group they are in.  Participants receiving the “sham” procedure may have the opportunity to have the therapy at a later time.

DOWNLOAD A PATIENT BROCHURE (PDF)

Am I a candidate for the study?

Are you between 18 and 75 years of age and…

  • Is your blood pressure greater than 140/90 mmHg despite being prescribed blood pressure medication?  or,
  • Is your blood pressure controlled (less than 140/90 mmHg) by one or two blood pressure medications but you would be interested in trying an alternative to medication? or,
  • Would you be willing to come off, or change, your current blood pressure medication if you were closely supervised?

IF YOU ANSWERED, “YES”, TO ANY OF THESE QUESTIONS, YOU MAY BE ELIGIBLE TO PARTICIPATE IN THE RADIANCE-HTN CLINICAL STUDY.

Am I a Candidate?

radiance-study-v2